SCHEMBL6660064

SCHEMBL6660064

CCOC(=O)c1nn(-c2ccc(S(N)(=O)=O)cc2)c2c1CCc1c-2ccn1Cc1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CA9 Q16790 9/20 0.50
CA1 P00915 6/20 0.47
CA2 P00918 6/20 0.47
CA4 P22748 6/20 0.47
KDM4E B2RXH2 2/20 0.47
ALDH1A1 P00352 2/20 0.47
HPGD P15428 2/20 0.47
TP53 P04637 1/20 0.47
CCNA2 P20248 4/20 0.47
CDK2 P24941 4/20 0.47
CCNA1 P78396 4/20 0.47
CA12 O43570 1/20 0.46
CHRNA7 P36544 2/20 0.45
IKBKB O14920 1/20 0.43
HSD17B10 Q99714 1/20 0.41
PTGS1 P23219 1/20 0.41
PTGS2 P35354 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6662893 0.88 CCNA2 (0.56) CA9CA1CA2CA4CCNA2
SCHEMBL6634331 0.87 CCNA2 (0.49) CA9CA1CA2CA4KDM4E
SCHEMBL6792450 0.79 CCNA2 (0.50) CA9KDM4EALDH1A1HPGDTP53
SCHEMBL6660718 0.78 CA9 (0.55) CA9CA1CA2CA4KDM4E
SCHEMBL5254020 0.76 CCNA2 (0.50) CA9CA1CA2CA4KDM4E
SCHEMBL5371941 0.76 CA9 (0.50) CA9CA1CA2CA4KDM4E
SCHEMBL5228990 0.76 CCNA2 (0.79) CCNA2CDK2CCNA1IKBKB
SCHEMBL5254155 0.76 CA9 (0.53) CA9CA1CA2CA4KDM4E
SCHEMBL6792114 0.76 CCNA2 (0.50) CA9CA1CA2CA4KDM4E
SCHEMBL6792645 0.76 CCNA2 (0.54) KDM4EALDH1A1HPGDTP53CCNA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1476431-A1 TRICYCLIC PYRAZOLE DERIVATIVES FOR THE TREATMENT OF INFLAMMATION Pharmacia Corporation (US) 2004-11-17 EP claimed
WO-2003070706-A1 TRICYCLIC PYRAZOLE DERIVATIVES FOR THE TREATMENT OF INFLAMMATION PHARMACIA CORPORATION (US) 2003-08-28 WO claimed
EP-1476431-A1 TRICYCLIC PYRAZOLE DERIVATIVES FOR THE TREATMENT OF INFLAMMATION Pharmacia Corporation (US) 2004-11-17 EP disclosed
WO-2003070706-A1 TRICYCLIC PYRAZOLE DERIVATIVES FOR THE TREATMENT OF INFLAMMATION PHARMACIA CORPORATION (US) 2003-08-28 WO disclosed